1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Data are scarce for the lifetime risk of developing impaired glucose metabolism, including prediabetes, as are data for the risk of eventual progression from prediabetes to diabetes and for initiation of insulin treatment in previously untreated patients with diabetes. We aimed to calculate the lifetime risk of the full range of glucose impairments, from normoglycaemia to prediabetes, type 2 diabetes, and eventual insulin use.

          Related collections

          Author and article information

          Journal
          Lancet Diabetes Endocrinol
          The lancet. Diabetes & endocrinology
          Elsevier BV
          2213-8595
          2213-8587
          Jan 2016
          : 4
          : 1
          Affiliations
          [1 ] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands.
          [2 ] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
          [3 ] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
          [4 ] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
          [5 ] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands; Inspectorate for Health Care, Utrecht, Netherlands.
          [6 ] Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
          [7 ] Department of Epidemiology, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address: a.dehghan@erasmusmc.nl.
          Article
          S2213-8587(15)00362-9
          10.1016/S2213-8587(15)00362-9
          26575606
          3a623962-9a5d-43b5-92a9-b0012ba09216
          History

          Comments

          Comment on this article